在重症监护病房的患者中,万科米辛最低度及其疗效和毒性的相关性
Teng Guo1, Li-Ying Du1, Ming-Feng Liu1
1Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang 050011, Hebei Province, China.
World journal of clinical cases
|June 9, 2025
概括
在重症监护室 (ICU) 中优化万科米辛治疗需要仔细监测. 这项研究确定了在ICU患者中有效和安全的万科迈辛血度间隔,以确定万科迈辛的疗效和降低毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 在重症监护室 (ICU) 中优化万科米辛的使用是至关重要的.
- 为有效治疗,确定万科米血度的参考间隔至关重要.
- 范科米对于治疗耐甲素黄金葡萄球菌感染至关重要.
研究的目的:
- 评估范科米辛在曲线下的面积 (AUC0-24) 和低谷度 (Cmin) 与治疗疗效之间的相关性.
- 评估万科米辛AUC0-24和Cmin与ICU患者毒性之间的关系.
- 在ICU中确定最佳的万科米辛度目标,以确保疗效和安全.
主要方法:
- 对103名ICU患者的分析,这些患者因甲素耐药性黄金葡萄球菌感染而接受了万科米辛治疗.
- 使用后勤回归评估临床人口统计因素和药物动力学参数 (Cmin,AUC0-24).
- 使用VCM-TDM软件与贝叶斯反计算AUC0-24.
主要成果:
- 超过359.6微克×小时/毫升的AUC0-24和超过9.4微克/毫升的Cmin表示有效的感染控制.
- 低于14.0微克/毫升的Cmin与没有显著的毒性有关.
- 确定的有效和安全的万科米辛度间隔为Cmin 9.4-14.0μg/mL.
结论:
- 该研究为ICU患者确定了有效和安全的万科米辛度范围 (Cmin 9.4-14.0 μg/mL).
- 建议密切监测万科米辛治疗,包括不良反应和功能.
- 这些发现有助于优化在重症监护机构的万科米辛剂量策略.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.6K
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
29.0K
相关概念视频
Drug Concentration Versus Time Correlation
660
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
660
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Therapeutic Index
4.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.1K
Determination of Michaelis Constant and Maximum Elimination Rate
73
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
73
